Korean J Hepatol.
1998 Mar;4(1):33-45.
Analysis of Cell Proliferative Activity, p53 Protein Overexpression and Apoptosis in Hepatocellular Carcinoma and Surrounding Nontumorous Liver
Abstract
- BACKGROUND/AIMS
Although the mechanism of hepatocellular carcinogenesis still
remains to be clarified, it has been suggested that persistent hepatic necrosis and resultant
irregular regeneration might cause genetic mutations, such as activation of protooncogenes,
inactivation of tumor suppressor genes and modulation of apoptosis-related genes,
finally leading to hepatocellular carcinoma (HCC). To elucidate the role of cell
proliferative activity and apoptosis, a major mechanism of cell death, in hepatocellular
carcinogenesis, we analyzed expression of proliferation cell nuclear antigen (PCNA),
p53 protein and apoptotic cells in HCC and surrounding nonneoplastic hepatic parenchyma.
METHODS
We performed immunohistochemical staining to detect P CAN, p53 protein,
and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling
(TUNEL) method for the detection of apoptosis in 52 hepatocellular carcinomas
and their adjacent nonneoplastic liver. We scored the expression of PCNA and p53,
and apoptotic index by a 5 point scale' 0, 0%,1, 1-25%', 2, 25-50%, 3, 50-75%',
4, >76%, and analyzed the results with other clinicopathologic characteristics.
RESULTS
p53 protein was expressed in 42.3% of the HCC, but was not evident
in nonneoplstic liver. P53 overexpression was correlated with the histologic grade
of HCC (p<0.05). PCNA labelling indices (LI) of HCC were correlated with those of
liver cell dysplasia and normal liver (p<0.05). Leading edges of HCCs showed higher
proliferative activity than the central part of HCC. Four cases of HCCs with high TUNEL
also showed high proliferative activity. There was no difference of the TUNEL between
HCC and surrounding nonneoplastic liver. Expression of p53, PCNA LI and TUNEL had
no relationship with clinicopathologic parameters including viral markers, aFP elevation,
tumor size and underlying cirrhosis.
CONCLUSION
p53 overexpression in HCC and absence of p53 mutation in nonneoplastic
liver indicates the active participation of p53 in hepatocellular carcinogenesis.
Invasiveness and metastatic potential appear to be related with the strong expression of PCNA,
but apoptosis in HCC has no direct implication in hepatocellular carinogensis.